Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Journal of the American Chemical Society
|
November 20, 2018
Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity
Qinqin Cheng, Xiaojing Shi, Menglu Han, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 24, 2022
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes
Qinqin Cheng, Zhefu Dai, Goar Smbatyan, et al.
Current Molecular Pharmacology
|
September 22, 2017
Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists
Yi Zhao, Kaijin Wu, Yongfeng Wu, et al.
Plos One
|
May 10, 2017
Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiation
Yi Zhao, Kaijin Wu, Cu Nguyen, et al.
Cancers
|
December 22, 2018
CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
Alexander Ring, Cu Nguyen, Goar Smbatyan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 18, 2019
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
Xiaojing Shi, Qinqin Cheng, Tianling Hou, et al.
Molecular Oncology
|
July 27, 2021
VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer
Nikhil Baban Ghate, Sangnam Kim, Erin Spiller, et al.
Journal of Neuro-Oncology
|
November 29, 2011
Novel cell lines established from pediatric brain tumors
Jingying Xu, Anat Erdreich-Epstein, Ignacio Gonzalez-Gomez, et al.
Blood
|
January 5, 2008
Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl
Hisham Abdel-Azim, Yuhua Zhu, Roger Hollis, et al.
Molecular Imaging
|
September 5, 2009
Metabolism of orthotopic mouse brain tumor models
Michael Rosol, Ira Harutyunyan, Jingying Xu, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Journal of the American Chemical Society
|
November 20, 2018
Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity
Qinqin Cheng, Xiaojing Shi, Menglu Han, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 24, 2022
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes
Qinqin Cheng, Zhefu Dai, Goar Smbatyan, et al.
Current Molecular Pharmacology
|
September 22, 2017
Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists
Yi Zhao, Kaijin Wu, Yongfeng Wu, et al.
Plos One
|
May 10, 2017
Small molecule p300/catenin antagonist enhances hematopoietic recovery after radiation
Yi Zhao, Kaijin Wu, Cu Nguyen, et al.
Cancers
|
December 22, 2018
CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
Alexander Ring, Cu Nguyen, Goar Smbatyan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 18, 2019
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
Xiaojing Shi, Qinqin Cheng, Tianling Hou, et al.
Molecular Oncology
|
July 27, 2021
VprBP directs epigenetic gene silencing through histone H2A phosphorylation in colon cancer
Nikhil Baban Ghate, Sangnam Kim, Erin Spiller, et al.
Journal of Neuro-Oncology
|
November 29, 2011
Novel cell lines established from pediatric brain tumors
Jingying Xu, Anat Erdreich-Epstein, Ignacio Gonzalez-Gomez, et al.
Blood
|
January 5, 2008
Expansion of multipotent and lymphoid-committed human progenitors through intracellular dimerization of Mpl
Hisham Abdel-Azim, Yuhua Zhu, Roger Hollis, et al.
Molecular Imaging
|
September 5, 2009
Metabolism of orthotopic mouse brain tumor models
Michael Rosol, Ira Harutyunyan, Jingying Xu, et al.
Page
of 2